Skip to content

Tybourne Capital Management (Hk) Ltd 13F Holdings · last filed Q3 2025

Tybourne Capital Management (Hk) Ltd reported 4 securities worth $30.93M in its SEC 13F filing for Q3 2025 (period ended 2025-09-30). Top holdings: TSHA (39.11%), FBRX (38.15%), ALMS (18.05%). Among its top 25 positions this quarter: 2 trimmed, 2 exited.

RankTickerCompanyValue% PortfolioSharesAction
1TSHATAYSHA GENE THERAPIES INC (TSHA US)$12.1M39.11%3.7MTrimmed
2FBRXFORTE BIOSCIENCES INC (FBRX US)$11.8M38.15%786,647Hold
3ALMSALUMIS INC (ALMS US)$5.6M18.05%1.4MHold
4ZNTLZENTALIS PHARMACEUTICALS INC (ZNTL US)$1.5M4.69%961,486Trimmed
5BCYCBICYCLE THERAPEUTICS LTD-ADR (BCYC US)$00.00%0Exited
6MBUUMALIBU BOATS INC (MBUU US)$00.00%0Exited

Source: SEC Form 13F filings · as of 2025-09-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR